[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605491":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":34,"centralContacts":39,"locations":48,"responsibleParty":69,"collaborators":29,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":29,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":51,"whyStopped":29,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"University of Lahore","OTHER",[8,15,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1: 675nm LLLT + RPT","EXPERIMENTAL","Single direct in-contact pencil probe, wavelength 675 nm, power 30 mW. Irradiance 222 mW\u002Fcm², fluence 6.7 J\u002Fcm², spot size 0.9 cm². Delivered in continuous and pulsed (2.5 Hz) modes, 6 Joules for 30 sec per treatment point (lymphatic chain, sub-occipital musculature, facet joints, nerve root exits, trigger points). Administered 3× weekly for 6 weeks (30 min\u002Fsession).\n\nDevice: Omega XP Model, Omega Laser Systems (UK) Class II therapeutic photobiomodulation device. Equipped with single direct in-contact pencil probes (675 nm, 30 mW; 820 nm, 200 mW) and a 46-cluster LED probe (mixed diodes 660-950 nm). Operates in continuous and pulsed (2.5 Hz) modes. Spot size 0.9-10 cm², irradiance 95-222 mW\u002Fcm², fluence 6.7-11.4 J\u002Fcm². CE-certified for therapeutic use; applied in this trial for cervicogenic headache management.",[13,14],"Device: Low-Level Laser Therapy (LLLT)","Other: Routine Physical Therapy (RPT)",{"label":16,"type":10,"description":17,"interventionNames":18},"Group 2: 820nm LLLT + RPT","Single direct in-contact pencil probe, wavelength 820 nm, power 200 mW. Irradiance 222 mW\u002Fcm², fluence 6.7 J\u002Fcm², spot size 0.9 cm². Delivered in continuous and pulsed (2.5 Hz) modes, 6 Joules for 30 sec per treatment point (same anatomical sites as Group 1). Administered 3× weekly for 6 weeks (30 min\u002Fsession).\n\nDevice: Omega XP Model, Omega Laser Systems (UK) Class II therapeutic photobiomodulation device. Equipped with single direct in-contact pencil probes (675 nm, 30 mW; 820 nm, 200 mW) and a 46-cluster LED probe (mixed diodes 660-950 nm). Operates in continuous and pulsed (2.5 Hz) modes. Spot size 0.9-10 cm², irradiance 95-222 mW\u002Fcm², fluence 6.7-11.4 J\u002Fcm². CE-certified for therapeutic use; applied in this trial for cervicogenic headache management.",[13,14],{"label":20,"type":10,"description":21,"interventionNames":22},"Group 3: 46 Cluster LED Probe + RPT","46-cluster LED probe combining 660 nm, 950 nm, 870 nm, 880 nm, 940 nm, 820 nm. Irradiance 95 mW\u002Fcm², fluence 11.4 J\u002Fcm², spot size 10 cm². Delivered in continuous and pulsed (2.5 Hz) modes, 114 Joules for 120 sec per treatment area (same anatomical sites as above). Administered 3× weekly for 6 weeks (30 min\u002Fsession).\n\nDevice: Omega XP Model, Omega Laser Systems (UK) Class II therapeutic photobiomodulation device. Equipped with single direct in-contact pencil probes (675 nm, 30 mW; 820 nm, 200 mW) and a 46-cluster LED probe (mixed diodes 660-950 nm). Operates in continuous and pulsed (2.5 Hz) modes. Spot size 0.9-10 cm², irradiance 95-222 mW\u002Fcm², fluence 6.7-11.4 J\u002Fcm². CE-certified for therapeutic use; applied in this trial for cervicogenic headache management.",[13,14],[24,30],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DEVICE","Low-Level Laser Therapy (LLLT)","Low-level laser therapy using the Omega XP Model with wavelengths of 675nm (30mW), 820nm (200mW), or 46-cluster LED probe (mixed wavelengths: 660nm, 950nm, 870nm, 880nm, 940nm, 820nm), applied three times weekly for 30 minutes over 6 weeks to target cervical lymphatic chain, musculature, and trigger points for pain relief in cervicogenic headache.",[9,16,20],null,{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":29},"Routine Physical Therapy (RPT)","Warm-up: Active cervical ROM (5-10 reps, pain-free range). Stretching: Upper trapezius, levator scapulae, SCM; hold 15-30 sec, 3-5 reps, NRS ≤ 3\u002F10. Therapeutic exercises: cervical deep flexors, scapular stabilization (2-3 sets × 10-15 reps, Borg 11-13), progressed weekly. Modalities: Hot pack 15 min at 40-45°C; TENS 80-100 Hz, 50-100 µs pulse width, 20 min. Frequency: 3× weekly for 6 weeks. Safety: contraindications screened; pain\u002Fexertion monitored pre\u002Fpost.",[9,16,20],[35],{"name":36,"affiliation":37,"role":38},"Umair Ahmed, PhD","University of Lahore, Lahore, Pakistan","STUDY_DIRECTOR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":29,"email":44},"AROOJ MUNAWAR, MS","CONTACT","00923214746780","arooj.munawar@uipt.uol.edu.pk",{"name":36,"role":42,"phone":46,"phoneExt":29,"email":47},"00923212700817","umair.ahmed@uipt.uol.edu.pk",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Department of Physiotherapy, Sir Ganga Ram Hospital","RECRUITING","Lahore","Punjab Province","54000","Pakistan","PK",{"type":58,"coordinates":59},"Point",[60,61],74.35071,31.558,{"lat":61,"lon":60},[64,66,67],{"name":65,"role":42,"phone":43,"phoneExt":29,"email":44},"Arooj Munawar, MSOMPT",{"name":36,"role":42,"phone":46,"phoneExt":29,"email":47},{"name":65,"role":68,"phone":29,"phoneExt":29,"email":29},"PRINCIPAL_INVESTIGATOR",{"type":68,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Arooj Munawar","Principal Investigator","100605491","therapeutic-efficacy-of-different-wavelengths-of-low-level-laser-therapy-in-the-treatment-of-cervicogenic-headache-100605491",false,"NCT07163208","Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache","WELL","Inclusion Criteria:\n\n* Patients aged 18-65 years diagnosed with cervicogenic headache based on the International Classification of Headache Disorders (ICHD-3) criteria.\n* Persistent headaches for at least 3 months.\n* No previous exposure to low-level laser therapy (LLLT).\n\nExclusion Criteria:\n\n* Patients with other primary headache disorders (e.g., migraine, tension-type headache).\n* History of cervical spine surgery.\n* Pregnant or lactating women.\n* Patients with a history of photosensitivity or taking photosensitizing medications.","ALL","18 Years","65 Years",{"count":83,"type":84},150,"ESTIMATED","INTERVENTIONAL",[87],"NA","This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.",[90],"Cervicogenic Headache",[90,92,93],"Low-Level Laser Therapy","Neck Pain","2025-09-15",{"date":96,"type":97},"2025-09-19","ACTUAL",{"date":99,"type":97},"2024-09-05",{"date":101,"type":84},"2025-10-05",{"name":5,"class":6},1]